Saiganesh Enzytech Solutions Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 29-10-2024
- Paid Up Capital ₹ 4.00 Cr
as on 29-10-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Saiganesh Enzytech Solutions
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mukund Kabra, Beni Rauka, Ankit Rathi, and One other member serve as directors at the Company.
- CIN/LLPIN
U01100MP2022PTC063261
- Company No.
063261
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2022
- Date of AGM
04 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Burhanpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saiganesh Enzytech Solutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Mutha  | Managing Director | 03-Jan-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankit Rathi | Director | 03-Jan-2023 | Current |
| Mukund Kabra | Director | 03-Jan-2023 | Current |
| Beni Rauka | Director | 03-Jan-2023 | Current |
Financial Performance and Corporate Structure Insights of Saiganesh Enzytech Solutions.
Saiganesh Enzytech Solutions Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Saiganesh Enzytech Solutions?
In 2023, Saiganesh Enzytech Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advanced Enzytech Solutions LimitedActive 16 years 3 monthsMukund Kabra and Beni Rauka are mutual person
Scitech Specialities Private LimitedActive 17 years 1 monthMukund Kabra and Beni Rauka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saiganesh Enzytech Solutions?
Saiganesh Enzytech Solutions has a workforce of 8 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saiganesh Enzytech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saiganesh Enzytech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
